4XAK image
Deposition Date 2014-12-15
Release Date 2015-08-26
Last Version Date 2024-10-30
Entry Detail
PDB ID:
4XAK
Keywords:
Title:
Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.45 Å
R-Value Free:
0.24
R-Value Work:
0.19
R-Value Observed:
0.20
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Spike glycoprotein
Gene (Uniprot):S
Chain IDs:A, D (auth: B)
Chain Length:252
Number of Molecules:2
Biological Source:Human coronavirus EMC
Polymer Type:polypeptide(L)
Molecule:Heavy chain of neutralizing antibody m336
Chain IDs:B (auth: H), E (auth: D)
Chain Length:252
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Light chain of neutralizing antibody m336
Chain IDs:C (auth: L), F (auth: E)
Chain Length:214
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody.
Nat Commun 6 8223 8223 (2015)
PMID: 26370782 DOI: 10.1038/ncomms9223

Abstact

The MERS-CoV is an emerging virus, which already infected more than 1,300 humans with high (∼36%) mortality. Here, we show that m336, an exceptionally potent human anti-MERS-CoV antibody, is almost germline with only one somatic mutation in the heavy chain. The structure of Fab m336 in complex with the MERS-CoV receptor-binding domain reveals that its IGHV1-69-derived heavy chain provides more than 85% binding surface and that its epitope almost completely overlaps with the receptor-binding site. Analysis of antibodies from 69 healthy humans suggests an important role of the V(D)J recombination-generated junctional and allele-specific residues for achieving high affinity of binding at such low levels of somatic hypermutation. Our results also have important implications for development of vaccine immunogens based on the newly identified m336 epitope as well as for elucidation of mechanisms of neutralization by m336-like antibodies and their elicitation in vivo.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback